The neurological presentations of childhood and adult mitochondrial disease: established syndromes and phenotypic variations.

[1]  M. Schlame,et al.  Remodeling of Cardiolipin by Phospholipid Transacylation* , 2003, Journal of Biological Chemistry.

[2]  C. Tzen,et al.  Melas with point mutations involving tRNALeu (A3243G) and tRNAGlu(A14693g) , 2003, Muscle & nerve.

[3]  S. Dimauro,et al.  Clinical and genetic heterogeneity in progressive external ophthalmoplegia due to mutations in polymerase gamma. , 2003, Archives of neurology.

[4]  A. Hutson,et al.  Efficacy of Dichloroacetate as a Lactate‐Lowering Drug , 2003, Journal of clinical pharmacology.

[5]  S. Dimauro,et al.  Mutation Screening in Patients With Isolated Cytochrome c Oxidase Deficiency , 2003, Pediatric Research.

[6]  F. Bernier,et al.  Diagnostic criteria for respiratory chain disorders in adults and children , 2002, Neurology.

[7]  S. Dimauro,et al.  Mitochondrial DNA depletion , 2002, Neurology.

[8]  Y. Akao,et al.  Gene Therapy for Mitochondrial Disease by Delivering Restriction Endonuclease SmaI into Mitochondria , 2002, Journal of Biomedical Science.

[9]  R. Wevers,et al.  Multiple mtDNA deletions with features of MNGIE , 2002, Neurology.

[10]  Alejandro A. Schäffer,et al.  Mutant deoxynucleotide carrier is associated with congenital microcephaly , 2002, Nature Genetics.

[11]  Salvatore DiMauro,et al.  Deficiency of tetralinoleoyl‐cardiolipin in Barth syndrome , 2002, Annals of neurology.

[12]  S. Dimauro,et al.  ANT1, Twinkle, POLG, and TP , 2001, Neurology.

[13]  H. Mandel,et al.  Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy , 2001, Nature Genetics.

[14]  S. Servidei.  Mitochondrial encephalomyopathies: gene mutation , 2001, Neuromuscular Disorders.

[15]  J. Sladky.  Histopathological Features of Peripheral Nerve and Muscle in Mitochondrial Disease , 2001, Seminars in neurology.

[16]  E. Holme,et al.  The incidence of mitochondrial encephalomyopathies in childhood: Clinical features and morphological, biochemical, and DNA abnormalities , 2001, Annals of neurology.

[17]  A. Gropman.  Diagnosis and treatment of childhood mitochondrial diseases , 2001, Current neurology and neuroscience reports.

[18]  C. Scriver,et al.  The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.

[19]  D. Turnbull,et al.  The epidemiology of pathogenic mitochondrial DNA mutations , 2000, Annals of neurology.

[20]  P. Kaplan,et al.  Differential features of patients with mutations in two COX assembly genes, SURF‐1 and SCO2 , 2000, Annals of neurology.

[21]  E. Shoubridge,et al.  Mutations in SCO2 are associated with a distinct form of hypertrophic cardiomyopathy and cytochrome c oxidase deficiency. , 2000, Human molecular genetics.

[22]  E. Shoubridge,et al.  Oxidative phosphorylation defect in the brains of carriers of the tRNAleu(UUR) A3243G mutation in a MELAS pedigree , 2000, Annals of neurology.

[23]  A. Schapira,et al.  Mitochondrial respiratory chain disorders II: neurodegenerative disorders and nuclear gene defects , 2000, The Lancet.

[24]  P. Kaplan,et al.  Fatal infantile cardioencephalomyopathy with COX deficiency and mutations in SCO2, a COX assembly gene , 1999, Nature Genetics.

[25]  S. Dimauro,et al.  Exercise intolerance due to mutations in the cytochrome b gene of mitochondrial DNA. , 1999, The New England journal of medicine.

[26]  G. Comi,et al.  Loss‐of‐function mutations of SURF‐1 are specifically associated with Leigh syndrome with cytochrome c oxidase deficiency , 1999, Annals of neurology.

[27]  S. Dimauro,et al.  Neonatal presentations of mitochondrial metabolic disorders. , 1999, Seminars in perinatology.

[28]  D. Wallace.  Mitochondrial diseases in man and mouse. , 1999, Science.

[29]  I. Nishino,et al.  Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. , 1999, Science.

[30]  V. Petruzzella,et al.  Identification and characterization of human cDNAs specific to BCS1, PET112, SCO1, COX15, and COX11, five genes involved in the formation and function of the mitochondrial respiratory chain. , 1998, Genomics.

[31]  H. Aotsuka,et al.  A follow up study of myocardial involvement in patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) , 1998, Heart.

[32]  C. Sue,et al.  Neuroradiological features of six kindreds with MELAS tRNALeu A3243G point mutation: implications for pathogenesis , 1998, Journal of neurology, neurosurgery, and psychiatry.

[33]  S. Dimauro,et al.  A new mitochondrial tRNAMet gene mutation in a patient with dystrophic muscle and exercise intolerance , 1998, Neurology.

[34]  S. Dimauro,et al.  Clinical manifestations of mitochondria1 DNA depletion , 1998, Neurology.

[35]  S. Love,et al.  Liver failure associated with mitochondrial DNA depletion. , 1998, Journal of hepatology.

[36]  S. Dimauro,et al.  Myoclonus epilepsy with ragged red fibers and multiple mtDNA deletions , 1998, Neurology.

[37]  L. Ketonen,et al.  Neuroradiologic findings in children with mitochondrial disorders. , 1998, AJNR. American journal of neuroradiology.

[38]  S. Dimauro,et al.  Multiple mtDNA deletions features in autosomal dominant and recessive diseases suggest distinct pathogeneses , 1998, Neurology.

[39]  S. Dimauro,et al.  Mitochondrial DNA Mutations and Pathogenesis , 1997, Journal of bioenergetics and biomembranes.

[40]  N. Howell.  Leber Hereditary Optic Neuropathy: How Do Mitochondrial DNA Mutations Cause Degeneration of the Optic Nerve? , 1997, Journal of bioenergetics and biomembranes.

[41]  I. Nonaka,et al.  Myoclonus epilepsy associated with ragged‐red fibers: A G‐to‐A mutation at nucleotide pair 8363 in mitochondrial tRNALys in two families , 1997, Muscle & nerve.

[42]  R. Rosenberg.  The Molecular and Genetic Basis of Neurological Disease , 1997 .

[43]  S. Dimauro,et al.  Mitochondrial myopathy simulating spinal muscular atrophy. , 1996, Pediatric neurology.

[44]  S. Dimauro,et al.  Genetic heterogeneity in leigh syndrome , 1996, Annals of neurology.

[45]  E. Shoubridge,et al.  Mitochondrial DNA depletion: prevalence in a pediatric population referred for neurologic evaluation. , 1996, Pediatric neurology.

[46]  J. Christodoulou,et al.  Leigh syndrome: Clinical features and biochemical and DNA abnormalities , 1996, Annals of neurology.

[47]  A. Munnich,et al.  Point mutation of the mitochondrial tRNA(Leu) gene (A 3243 G) in maternally inherited hypertrophic cardiomyopathy, diabetes mellitus, renal failure, and sensorineural deafness. , 1995, Journal of medical genetics.

[48]  M. Miyata,et al.  Cardiac involvement in mitochondrial diseases. A study on 17 patients with documented mitochondrial DNA defects. , 1995, Circulation.

[49]  D. Wallace,et al.  A mitochondrial DNA mutation at nucleotide pair 14459 of the NADH dehydrogenase subunit 6 gene associated with maternally inherited Leber hereditary optic neuropathy and dystonia. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[50]  Anthony H.V. Schapira,et al.  Mitochondrial Disorders in Neurology , 1994 .

[51]  S. Dimauro,et al.  A T → C mutation at nt 8993 of mitochondrial DNA in a child with Leigh syndrome , 1994, Neurology.

[52]  S. Dimauro,et al.  Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) , 1994, Neurology.

[53]  P. M. Matthews,et al.  Proton MR spectroscopic characterization of differences in regional brain metabolic abnormalities in mitochondrial encephalomyopathies , 1993, Neurology.

[54]  S. Dimauro,et al.  The mutation at nt 8993 of mitochondrial DNA is a common cause of Leigh's syndrome , 1993, Annals of neurology.

[55]  N. Newman,et al.  Variable retinal and neurologic manifestations in patients harboring the mitochondrial DNA 8993 mutation. , 1993, Archives of ophthalmology.

[56]  S. Dimauro,et al.  Valproic Acid Impairs Carnitine Uptake in Cultured Human Skin Fibroblasts. An In Vitro Model for the Pathogenesis of Valproic Acid–Associated Carnitine Deficiency , 1993, Pediatric Research.

[57]  F. Gabreëls,et al.  A second missense mutation in the mitochondrial ATPase 6 gene in Leigh's syndrome , 1993, Annals of neurology.

[58]  J. Cooper,et al.  Nuclear complementation restores mtDNA levels in cultured cells from a patient with mtDNA depletion. , 1993, American journal of human genetics.

[59]  A. Barkovich,et al.  Mitochondrial disorders: analysis of their clinical and imaging characteristics. , 1993, AJNR. American journal of neuroradiology.

[60]  A. Harding,et al.  The mitochondrial DNA transfer RNA(Lys)A-->G(8344) mutation and the syndrome of myoclonic epilepsy with ragged red fibres (MERRF). Relationship of clinical phenotype to proportion of mutant mitochondrial DNA. , 1993, Brain : a journal of neurology.

[61]  S. M. Sumi,et al.  Phenotypic heterogeneity in families with the myoclonic epilepsy and ragged‐red fiber disease point mutation in mitochondrial DNA , 1993, Annals of neurology.

[62]  S. Dimauro,et al.  Maternally inherited Leigh syndrome. , 1993, The Journal of pediatrics.

[63]  E. Holme,et al.  Leber's hereditary optic neuropathy and complex I deficiency in muscle , 1991, Annals of neurology.

[64]  E. Holme,et al.  Mitochondrial encephalomyopathies in childhood. II. Clinical manifestations and syndromes. , 1991, The Journal of pediatrics.

[65]  A. Harding,et al.  Mitochondrial encephalopathies: molecular genetic diagnosis from blood samples , 1991, The Lancet.

[66]  M. Tulinius,et al.  EEG findings in children and adolescents with mitochondrial encephalomyopathies: A study of 25 cases , 1991, Brain and Development.

[67]  S. Dimauro,et al.  mtDNA depletion with variable tissue expression: a novel genetic abnormality in mitochondrial diseases. , 1991, American journal of human genetics.

[68]  E. Shoubridge,et al.  Myoclonus epilepsy and ragged-red fibres (MERRF). 1. A clinical, pathological, biochemical, magnetic resonance spectrographic and positron emission tomographic study. , 1989, Brain : a journal of neurology.

[69]  S. Dimauro,et al.  An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting at the D-loop region , 1989, Nature.

[70]  A. Carter,et al.  CT and MR of MELAS syndrome. , 1988, AJNR. American journal of neuroradiology.

[71]  S. Dimauro,et al.  Myo-, neuro-, gastrointestinal encephalopathy (MNGIE syndrome) due to partial deficiency of cytochrome-c-oxidase , 1987, Acta Neuropathologica.

[72]  F. Gabreëls,et al.  Mitochondrial Encephalomyopathy: Association With an NADH Dehydrogenase Deficiency , 1987 .

[73]  S. Packman,et al.  Pyruvate dehydrogenase complex deficiency as a cause of subacute necrotizing encephalopathy (Leigh disease). , 1987, Pediatrics.

[74]  S. Dimauro,et al.  Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: A distinctive clinical syndrome , 1984, Annals of neurology.

[75]  K. Dam,et al.  Leigh's encephalomyelopathy in a patient with cytochrome c oxidase deficiency in muscle tissue. , 1977, Pediatrics.

[76]  S. Dimauro,et al.  Lumping or splitting? “ophthalmoplegia‐plus” or kearns‐sayre syndrome? , 1977, Annals of neurology.

[77]  D. Leigh.  SUBACUTE NECROTIZING ENCEPHALOMYELOPATHY IN AN INFANT , 1951, Journal of neurology, neurosurgery, and psychiatry.

[78]  T. Miyatake,et al.  Mitochondrial angiopathy in cerebral blood vessels of mitochondrial eneephalomyopathy , 2004, Acta Neuropathologica.

[79]  E. Shoubridge,et al.  Mutations in COX15 produce a defect in the mitochondrial heme biosynthetic pathway, causing early-onset fatal hypertrophic cardiomyopathy. , 2003, American journal of human genetics.

[80]  E. Schon,et al.  Clinical syndromes associated with ragged red fibers. , 1991, Revue neurologique.

[81]  D. Wallace,et al.  Oxidative Phosphorylation Diseases , 1990 .